Ignite Creation Date:
2025-12-24 @ 11:33 PM
Ignite Modification Date:
2026-02-19 @ 11:42 PM
Study NCT ID:
NCT00988156
Status:
COMPLETED
Last Update Posted:
2018-11-13
First Post:
2009-10-01
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Eslicarbazepine Acetate (BIA 2 093) as Therapy for Refractory Partial Seizures in Children
Sponsor:
Bial - Portela C S.A.
Organization:
Organization Data
Organization:
Class:
INDUSTRY
Study ID:
BIA-2093-305
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None